Dr. Stuart M. Weiss, M.D.
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 409
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
NY license 175583
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- NYU Langone Hospitals New York, NY
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 409
- Services billed
- 3,976
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 943 | 339 |
| Insertion of needle into vein for collection of blood sample | 731 | 312 |
| Hemoglobin a1c level | 608 | 264 |
| Blood glucose (sugar) level | 606 | 252 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 334 | 141 |
| Established patient office or other outpatient visit, 20-29 minutes | 118 | 98 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 90 | 81 |
| Established patient office or other outpatient visit, 10-19 minutes | 60 | 50 |
| New patient office or other outpatient visit, 45-59 minutes | 54 | 54 |
| Injection of drug or substance under skin or into muscle | 49 | 38 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Jardiance (empagliflozin) Other prescribers in New York, NY | 564 |
| Ozempic (semaglutide) Other prescribers in New York, NY | 396 |
| Mounjaro (tirzepatide) Other prescribers in New York, NY | 337 |
| Metformin Hcl Other prescribers in New York, NY | 326 |
| Levothyroxine Sodium Other prescribers in New York, NY | 196 |
| Farxiga (dapagliflozin propanediol) Other prescribers in New York, NY | 187 |
| Pioglitazone Hcl Other prescribers in New York, NY | 150 |
| Metformin Hcl Er (metformin hcl) Other prescribers in New York, NY | 135 |
| Atorvastatin Calcium Other prescribers in New York, NY | 116 |
| Trulicity (dulaglutide) Other prescribers in New York, NY | 85 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 75 payments worth $2,599 in total to this clinician.
| Novo Nordisk Inc | $459 |
|---|---|
| Lilly USA, LLC | $453 |
| Beta Bionics, Inc. | $309 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229 |
| Mannkind Corporation | $226 |
| Merck Sharp & Dohme LLC | $127 |
| Amgen Inc. | $115 |
| Corcept Therapeutics | $107 |
| Food and Beverage | $2,599 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.